Health of children born through artificial oocyte activation: A pilot study

Reproductive Sciences

Volumn 22, Issue 3, 2015, Pages 322-328

  Deemeh, Mohammad R ^a   Tavalaee, Marziyeh ^a   Nasr Esfahani, Mohammad H ^a,b  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

artificial oocyte activation; birth defects; ICSI

Indexed keywords

IONOMYCIN; CALCIUM IONOPHORE;

ABORTION; ADULT; ARTICLE; ARTIFICIAL OOCYTE ACTIVATION; BIRTH DEFECT; CHILD HEALTH; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FERTILIZATION; HUMAN; INFANT; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MENTAL HEALTH; OUTCOME ASSESSMENT; PILOT STUDY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; TESTICULAR SPERM EXTRACTION; ADVERSE EFFECTS; AGE; CALCIUM SIGNALING; CHILD BEHAVIOR; CHILD DEVELOPMENT; DRUG EFFECTS; HEALTH STATUS; INFERTILITY, MALE; MALE; METABOLISM; OOCYTE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS; PRESCHOOL CHILD; RISK FACTOR; TREATMENT OUTCOME;

AGE FACTORS; CALCIUM IONOPHORES; CALCIUM SIGNALING; CHILD BEHAVIOR; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HEALTH STATUS; HUMANS; INFANT; INFERTILITY, MALE; IONOMYCIN; MALE; MENTAL HEALTH; OOCYTES; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 84924764600     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114542017     Document Type: Article

References (30)

1. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992; 340 (8810). 17-18
2. Van Steirteghem A, Liu J, Nagy Z, et al. Use of assisted fertilization. Hum Reprod. 1993; 8 (11). 1784-1785
3. Aghajanpour S, Ghaedi K, Salamian A, et al. Quantitative expression of phospholipase C zeta, as an index to assess fertilization potential of a semen sample. Hum Reprod. 2001; 26 (11). 2950-2956
4. Vanden Meerschaut F, Nikiforaki D, De Gheselle S, et al. Assisted oocyte activation is not beneficial for all patients with a suspected oocyte-related activation deficiency. Hum Reprod. 2012; 27 (7). 1977-1984
5. Nasr-Esfahani MH, Deemeh MR, Tavalaee M. Artificial oocyte activation and intracytoplasmic sperm injection [review]. Fertil Steril. 2010; 94 (2). 520-526
6. Borges E, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A, Franco JG. Artificial oocyte activation using calcium ionophore in ICSI cycles with spermatozoa from different sources. Reprod Biomed Online. 2009; 18 (1). 45-52
7. Ebner T, Köster M, Shebl O, et al. Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril. 2012; 98 (6). 1432-1437
8. Ahmadi SE, Nateghi MR, Gourabi H, et al. Frequency of hearing defect and ear abnormalities in newborns conceived by assisted reproductive techniques in Royan institute. Int J Fertil Steril. 2010; 4 (2). 79-84
9. Leunens L, Celestin-Westreich S, Bonduelle M, Liebaers I, Ponjaert-Kristoffersen I. Follow-up of cognitive and motor development of 10-year-old singleton children born after ICSI compared with spontaneously conceived children. Hum Reprod. 2008; 23 (1). 105-111
10. Moaz MN, Khattab S, Foutouh IA, Mohsen EA. Chemical activation of oocytes in different types of sperm abnormalities in cases of low or failed fertilization after ICSI: a prospective pilot study. Reprod Biomed Online. 2006; 13 (6). 791-794
11. Nasr-Esfahani MH, Razavi S, Javdan Z, Tavalaee M. Artificial oocyte activation in severe teratozoospermia undergoing intracytoplasmic sperm injection. Fertil Steril. 2008; 90 (6). 2231-2237
12. Soltani R, Parsai S Health of Mother and Child. Tehran: Sanjesh Publication; 2006 :
13. Barnes KE, Stark A. The Denver developmental screening test a normative study. Am J Public Health. 1975; 65 (4). 363-369
14. Fan W, Li SW, Li L, et al. Outcome of conventional IVF and ICSI on sibling oocytes in the case of isolated teratozoospermia. J Assist Reprod Genet. 2012; 29 (9). 905-910
15. Naru T, Sulaiman MN, Kidwai A, et al. Intracytoplasmic sperm injection outcome using ejaculated sperm and retrieved sperm in azoospermic men. Urol J. 2008; 5 (2). 106-110
16. Wang JX, Norman RJ, Wilcox AJ. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod. 2004; 19 (2). 272-277
17. Bridges PJ, Jeoung M, Kim H, et al. Methodology matters: IVF versus ICSI and embryonic gene expression. Reprod Biomed Online. 2011; 23 (2). 234-244
18. Makhseed M, Al-Sharhan M, Egbase P, Al-Essa M, Grudzinskas JG. Maternal and perinatal outcomes of multiple pregnancy following IVF-ET. Int J Gynaecol Obstet. 1998; 61 (2). 155-163
19. Pinborg A, Loft A, Schmidt L, Andersen AN. Morbidity in a Danish national cohort of 472 IVF/ICSI twins, 1132 non-IVF/ICSI twins and 634 IVF/ICSI singletons: health-related and social implications for the children and their families. Hum Reprod. 2003; 18 (6). 1234-1243
20. Yazdizadeh B, Nedjat S, Mohammad K, Rashidian A, Changizi N, Majdzadeh R. Cesarean section rate in Iran, multidimensional approaches for behavioral change of providers: a qualitative study. BMC Health Serv Res. 2011; 11: 1-14
21. Kurinczuk JJ, Bower C. Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation. BMJ. 1997; 315 (7118). 1260-1265
22. Lie RT, Lyngstadaas A, Qrstavik KH, Bakketeig LS, Jacobsen G, Tanbo T. Birth defects in children conceived by ICSI compared with children conceived by other IVF-methods; a meta-analysis. Int J Epidemiol. 2005; 34 (3). 696-701
23. Porter MP, Faizan MK, Grady RW, Mueller BA. Hypospadias in Washington State: maternal risk factors and prevalence trends. Pediatrics. 2005; 115 (4). e495-e499
24. Terada Y, Hasegawa H, Takahashi A, Ugajin T, Yaegashi N, Okamura K. Successful pregnancy after oocyte activation by a calcium ionophore for a patient with recurrent intracytoplasmic sperm injection failure, with an assessment of oocyte activation and sperm centrosomal function using bovine eggs. Fertil Steril. 2009; 91 (3). 935
25. Saadat M, Ansari-Lari M, Farhud DD. Consanguineous marriage in Iran. Ann Hum Biol. 2004; 31 (2). 263-269
26. Pinborg A. IVF/ICSI twin pregnancies: risks and prevention. Hum Reprod Update. 2005; 11 (6). 575-593
27. Kyono K, Kumagai S, Nishinaka C, et al. Birth and follow-up of babies born following ICSI using SrCl2 oocyte activation. Reprod Biomed Online. 2008; 17 (1). 53-58
28. Kyono K, Takisawa T, Nakajo Y, Doshida M, Toya M. Birth and follow-up of babies born following ICSI with oocyte activation using strontium chloride or calcium lonophore A23187. J Mamm Ova Res. 2012; 29 (1). 35-40
29. Heindryckx B, De Gheselle S, Gerris J, Dhont M, De Sutter P. Efficiency of assisted oocyte activation as a solution for failed intracytoplasmic sperm injection. Reprod Biomed Online. 2008; 17 (5). 662-668
30. Montag M, Köster M, van der Ven K, Bohlen U, van der Ven H. The benefit of artificial oocyte activation is dependent on the fertilization rate in a previous treatment cycle. Reprod Biomed Online. 2012; 24 (5). 521-526